Literature DB >> 17928352

The U95 protein of human herpesvirus 6B interacts with human GRIM-19: silencing of U95 expression reduces viral load and abrogates loss of mitochondrial membrane potential.

W M Yeo1, Yuji Isegawa, Vincent T K Chow.   

Abstract

To better understand the pathogenesis of human herpesvirus 6 (HHV-6), it is important to elucidate the functional aspects of immediate-early (IE) genes at the initial phase of the infection. To study the functional role of the HHV-6B IE gene encoding U95, we generated a U95-Myc fusion protein and screened a pretransformed bone marrow cDNA library for U95-interacting proteins, using yeast-two hybrid analysis. The most frequently appearing U95-interacting protein identified was GRIM-19, which belongs to the family of genes associated with retinoid-interferon mortality and serves as an essential component of the oxidative phosphorylation system. This interaction was verified by both coimmunoprecipitation and confocal microscopic coimmunolocalization. Short-term HHV-6B infection of MT-4 T-lymphocytic cells induced syncytial formation, resulted in decreased mitochondrial membrane potential, and led to progressively pronounced ultrastructural changes, such as mitochondrial swelling, myelin-like figures, and a loss of cristae. Compared to controls, RNA interference against U95 effectively reduced the U95 mRNA copy number and abrogated the loss of mitochondrial membrane potential. Our results indicate that the high affinity between U95 early viral protein and GRIM-19 may be closely linked to the detrimental effect of HHV-6B infection on mitochondria. These findings may explain the alternative cell death mechanism of expiration, as opposed to apoptosis, observed in certain productively HHV-6B-infected cells. The interaction between U95 and GRIM-19 is thus functionally and metabolically significant in HHV-6B-infected cells and may be a means through which HHV-6B modulates cell death signals by interferon and retinoic acid.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17928352      PMCID: PMC2224593          DOI: 10.1128/JVI.01156-07

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  43 in total

1.  Complex I deficiency in Persian multiple sclerosis patients.

Authors:  Hassan H Kumleh; Gholam H Riazi; Massoud Houshmand; Mohammad H Sanati; Kourosh Gharagozli; Mehdi Shafa
Journal:  J Neurol Sci       Date:  2006-01-18       Impact factor: 3.181

Review 2.  Mitochondria as functional targets of proteins coded by human tumor viruses.

Authors:  Donna M D'Agostino; Paolo Bernardi; Luigi Chieco-Bianchi; Vincenzo Ciminale
Journal:  Adv Cancer Res       Date:  2005       Impact factor: 6.242

3.  Comparison of the complete DNA sequences of human herpesvirus 6 variants A and B.

Authors:  Y Isegawa; T Mukai; K Nakano; M Kagawa; J Chen; Y Mori; T Sunagawa; K Kawanishi; J Sashihara; A Hata; P Zou; H Kosuge; K Yamanishi
Journal:  J Virol       Date:  1999-10       Impact factor: 5.103

4.  An encephalitic episode in a multiple sclerosis patient with human herpesvirus 6 latent infection.

Authors:  E Merelli; P Sola; P Barozzi; G Torelli
Journal:  J Neurol Sci       Date:  1996-04       Impact factor: 3.181

5.  Mitochondrial dysfunction plays a key role in progressive axonal loss in Multiple Sclerosis.

Authors:  H E Andrews; P P Nichols; D Bates; D M Turnbull
Journal:  Med Hypotheses       Date:  2005       Impact factor: 1.538

6.  GRIM-19 interacts with nucleotide oligomerization domain 2 and serves as downstream effector of anti-bacterial function in intestinal epithelial cells.

Authors:  Nicolas Barnich; Tadakazu Hisamatsu; Jose E Aguirre; Ramnik Xavier; Hans-Christian Reinecker; Daniel K Podolsky
Journal:  J Biol Chem       Date:  2005-03-07       Impact factor: 5.157

7.  Apoptosis occurs predominantly in bystander cells and not in productively infected cells of HIV- and SIV-infected lymph nodes.

Authors:  T H Finkel; G Tudor-Williams; N K Banda; M F Cotton; T Curiel; C Monks; T W Baba; R M Ruprecht; A Kupfer
Journal:  Nat Med       Date:  1995-02       Impact factor: 53.440

8.  Phenotypic changes in mitochondrial membrane potential (Delta psi(m)) during valinomycin-induced depolarisation and apoptosis.

Authors:  M L Morrison; K Williamson; K Arthur; G J Price; P W Hamilton; P Maxwell
Journal:  Cell Oncol       Date:  2005       Impact factor: 6.730

9.  Transcriptomic and proteomic analyses of rhabdomyosarcoma cells reveal differential cellular gene expression in response to enterovirus 71 infection.

Authors:  Wai Fook Leong; Vincent T K Chow
Journal:  Cell Microbiol       Date:  2006-04       Impact factor: 3.715

10.  Phenotypic alterations and survival of monocytes following infection by human herpesvirus-6.

Authors:  M-E Janelle; L Flamand
Journal:  Arch Virol       Date:  2006-02-13       Impact factor: 2.574

View more
  10 in total

Review 1.  The Putative Role of Viruses, Bacteria, and Chronic Fungal Biotoxin Exposure in the Genesis of Intractable Fatigue Accompanied by Cognitive and Physical Disability.

Authors:  Gerwyn Morris; Michael Berk; Ken Walder; Michael Maes
Journal:  Mol Neurobiol       Date:  2015-06-17       Impact factor: 5.590

Review 2.  Laboratory and clinical aspects of human herpesvirus 6 infections.

Authors:  Henri Agut; Pascale Bonnafous; Agnès Gautheret-Dejean
Journal:  Clin Microbiol Rev       Date:  2015-04       Impact factor: 26.132

Review 3.  GRIM-19: A master regulator of cytokine induced tumor suppression, metastasis and energy metabolism.

Authors:  Shreeram C Nallar; Dhan V Kalvakolanu
Journal:  Cytokine Growth Factor Rev       Date:  2016-09-15       Impact factor: 7.638

4.  Immunomodulation and immunosuppression by human herpesvirus 6A and 6B.

Authors:  Lorenzo Dagna; Joshua C Pritchett; Paolo Lusso
Journal:  Future Virol       Date:  2013-03       Impact factor: 1.831

5.  GRIM-19 inhibition induced autophagy through activation of ERK and HIF-1α not STAT3 in Hela cells.

Authors:  Xin Yue; Peiwei Zhao; Kongming Wu; Juan Huang; Wen Zhang; Yaogui Wu; Xiaohui Liang; Xuelian He
Journal:  Tumour Biol       Date:  2016-01-25

6.  GRIM-19 disrupts E6/E6AP complex to rescue p53 and induce apoptosis in cervical cancers.

Authors:  Ying Zhou; Ying Wei; Jing Zhu; Qingyuan Wang; Liang Bao; Yang Ma; Yu Chen; Dingqing Feng; Aijin Zhang; Jie Sun; Shreeram C Nallar; Keng Shen; Dhananjaya V Kalvakolanu; Weihua Xiao; Bin Ling
Journal:  PLoS One       Date:  2011-07-12       Impact factor: 3.240

7.  Complete Genome Sequence of Germline Chromosomally Integrated Human Herpesvirus 6A and Analyses Integration Sites Define a New Human Endogenous Virus with Potential to Reactivate as an Emerging Infection.

Authors:  Joshua Tweedy; Maria Alexandra Spyrou; Max Pearson; Dirk Lassner; Uwe Kuhl; Ursula A Gompels
Journal:  Viruses       Date:  2016-01-15       Impact factor: 5.048

Review 8.  Human Herpesvirus 6 and Malignancy: A Review.

Authors:  Eva Eliassen; Emily Lum; Joshua Pritchett; Joseph Ongradi; Gerhard Krueger; John R Crawford; Tuan L Phan; Dharam Ablashi; Stanley David Hudnall
Journal:  Front Oncol       Date:  2018-11-13       Impact factor: 6.244

9.  Whole genome diversity of inherited chromosomally integrated HHV-6 derived from healthy individuals of diverse geographic origin.

Authors:  Marco Telford; Arcadi Navarro; Gabriel Santpere
Journal:  Sci Rep       Date:  2018-02-22       Impact factor: 4.379

Review 10.  Chronic viral infections in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS).

Authors:  Santa Rasa; Zaiga Nora-Krukle; Nina Henning; Eva Eliassen; Evelina Shikova; Thomas Harrer; Carmen Scheibenbogen; Modra Murovska; Bhupesh K Prusty
Journal:  J Transl Med       Date:  2018-10-01       Impact factor: 5.531

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.